Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

The topical treatment reduced hair loss and improved hair growth in patients with certain types of hair loss.

Thyroid autoimmunity may be involved in some female hair loss, suggesting the need to test for thyroid antibodies in these patients.

Hair loss in a child was an early sign of Crohn's disease.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

Iron deficiency may contribute to chronic hair loss in premenopausal women.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

Indian dermatologists recommend treating common hair loss with a balanced diet, stress reduction, mild shampoos, and sometimes minoxidil and supplements.

The study suggests that mast cells might be involved in the hair loss condition telogen effluvium and could be a target for treatment.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Certain growth factors significantly affect hair loss in women with telogen effluvium.

Some people experienced hair loss after COVID-19 vaccination, but it's very rare and vaccines' benefits are greater than this risk.

Telogen effluvium is a condition that causes temporary hair loss due to stress or shock to the body.

The document concludes that a new treatment for a type of hair loss called telogen effluvium was tested and shows promise.

COVID-19 can cause hair loss in both severe and mild cases, often affecting women.

Topical imiquimod use for treating a cervical lesion might cause delayed hair loss.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

Hair casts may be a useful clue for diagnosing hair loss during the resting phase of hair growth.

Horizontally sectioned scalp biopsies are more reliable for diagnosing hair loss in women when three samples are taken instead of one.

Imiquimod used intravaginally for cervical issues can cause temporary hair loss, especially if severe side effects occur.

Obese mice with a leptin gene mutation have a longer resting phase in their hair cycle, which may help understand certain hair loss conditions.

Hair loss in Cronkhite-Canada syndrome may be due to an autoimmune response.

People with certain types of hair loss, especially lichen planopilaris and telogen effluvium, as well as African Americans, Asians, and men, are more likely to have severe vitamin D deficiency.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

Low-dose oral minoxidil effectively treats non-scarring hair loss with some side effects like hypertrichosis and postural hypotension.

A COVID-19 patient with severe hair loss did not improve with hair loss medication after stopping and restarting it due to the infection.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Many dermatologists in Saudi Arabia recommend vitamins and minerals for hair loss, often based on personal experience rather than strong evidence.

Low iron and vitamin D levels are linked to hair loss in women.